Table 1.
Patient characteristics.
| All patients (n = 207), n (%) |
With CT (n = 143), n (%) |
Without CT (n = 64), n (%) |
||
|---|---|---|---|---|
| Age, year | Median (range) | 75 (65–92) | 73 (65–86) | 80 (66–92) |
| Sex | Male | 109 (52.7) | 76 (53.1) | 33 (51.6) |
| Female | 98 (47.3) | 67 (46.9) | 31 (48.4) | |
| PS | 0 | 98 (47.3) | 83 (58.0) | 15 (23.4) |
| 1 | 88 (42.5) | 58 (40.6) | 30 (46.9) | |
| ≥2 | 15 (7.2) | 1 (0.7) | 14 (21.9) | |
| Unknown | 6 (2.9) | 1 (0.7) | 5 (7.8) | |
| BMI | Median (range) | 20.8 (13.5–31.6) | 21.0 (13.5–31.6) | 20.0 (14.8–27.5) |
| Cancer type | Colon/Rectum | 108 (52.2) | 75 (52.4) | 33 (51.6) |
| Pancreas | 60 (29.0) | 41 (28.7) | 19 (29.7) | |
| Stomach | 39 (18.8) | 27 (18.9) | 12 (18.7) | |
| Staging | Resectable | 92 (44.4) | 63 (44.1) | 29 (45.3) |
| Unresectable | 115 (55.6) | 80 (55.9) | 35 (54.7) | |
| Treatment | Palliative CT | 80 (38.6) | 80 (55.9) | – |
| Adjuvant CT | 63 (30.4) | 63 (44.1) | – | |
| No CT | 64 (31.0) | – | 64 (100) | |
-, not applicable; PS, performance status; BMI, body mass index; CT, chemotherapy.